Berkshire Hathaway, a global phenomenon in the holdings industry, recently invested in additional shares from a company named DaVita, a kidney dialysis center operator. After the announcement of the shares sale in December of 2017, DaVita saw a rise in their stock prices almost instantly. With this investment, Berkshire Hathaway, along with CEO and Chairman Warren G. Buffett, now hold the largest amount of shares in the healthcare company. Currently holding a whooping 20 percent of DaVita’s company shares, Berkshire Hathaway holds the means to profit more than $231 million in a single day’s paper count. Although the purchase of DaVita shares is not the first time that Berkshire Hathaway, or Warren G. Buffett, has invested in the healthcare sector, this is the first majorly profitable investment of healthcare shares.
DaVita is currently in operation of more than 300 different healthcare clinics, a number of outpatient surgery centers throughout six different states and continues to hold it’s main focus on the kidney care industry, including a top priority of the kidney dialysis factors in healthcare. The company has stated that they intend to use the proceeds from the shares sale to buy back other stocks and begin to make strides towards investing in other healthcare related topics. Berkshire Hathaway, under the supervision of Warren G. Buffett, has held shares with DaVita since 2011. The healthcare company has ranked among the top favorites with Berkshire’s portfolio manager, Ted Weschler, who is also credited with holding personal shares in the DaVita company as well.